Both the NASDAQ and S&P indices have achieved new intraday record highs at the start of trading today. The NASDAQ is up by 0.55%, with the small-cap Russell 2000 also increasing by approximately 0.55%. The Dow industrial average is fluctuating around the unchanged mark without a new record for 2025.
Market Updates
Market updates show the Dow industrial average gaining 13 points or 0.04% at 44853. The S&P index rose by 14.12 points or 0.22% at 6404.10, while the NASDAQ index increased by 107 points or 0.51% at 21285. The small-cap Russell 2000 advanced by 11.14 points or 0.50% at 2268.
Regarding individual stocks, Novo Nordisk’s shares fell over 20% due to reduced guidance and leadership changes. Eli Lilly shares decreased by 4%. Merck’s revenue miss and guidance adjustment led to a decline, while Boeing’s shares fell by 0.79% despite improved plane deliveries. Union Pacific plans to acquire Norfolk Southern for $85B. Nvidia’s shares rose by 1.20%, trading at record levels.
Meanwhile, AMD’s shares climbed by 2.88%, surpassing the October 2024 high. Amazon and Apple are set to report earnings on Thursday, with Microsoft and Meta announcing after the FOMC rate decision on Wednesday.
We see a divided market where the tech-heavy Nasdaq and S&P 500 are making new highs, while the Dow Jones Industrial Average lags behind. This divergence suggests a focused momentum in specific sectors rather than a broad, all-encompassing rally. Our strategy must account for this split personality in the market.
Semiconductor Stocks Trend
The sustained strength in semiconductor stocks like Nvidia and AMD is a clear trend to follow. With Nvidia securing large chip orders and AMD breaking past its previous highs, we are looking at buying call options to capitalize on further upward movement. Tech-focused ETFs like the QQQ are also prime candidates for bull call spreads, which can limit risk while capturing upside.
This week is all about event-driven volatility, with major tech earnings and an FOMC rate decision on Wednesday. The CBOE Volatility Index (VIX) is currently trading near 14, which is historically low and makes buying options relatively inexpensive. We believe purchasing straddles or strangles on names like Amazon and Meta is a smart way to play the large price swings expected after they report earnings.
The weakness in healthcare, shown by sharp drops in Novo Nordisk, UnitedHealth, and Merck, presents a different kind of opportunity. We are considering buying put options on these individual stocks or on the broader healthcare ETF (XLV) to hedge against further downside. So far this earnings season, misses have been punished severely, with stocks falling an average of 5.1% the next day, a trend these companies exemplify.
With the Dow failing to confirm the new highs, there is a clear non-participation from industrial and blue-chip names. This weakness, combined with the S&P 500 trading at a historically high forward P/E ratio of over 23, makes a compelling case for protective strategies. We are looking at buying puts on the SPY as a cost-effective hedge to protect our long positions against a potential market pullback.
The Federal Reserve’s rate decision is the week’s main event and will likely impact all sectors. Fed funds futures are currently pricing in a 70% probability that the Fed will hold rates steady, so any surprise language in their statement could cause significant market moves. We will remain nimble, ready to adjust our positions based on the Fed’s tone regarding future policy.
